全文获取类型
收费全文 | 1903篇 |
免费 | 87篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 46篇 |
儿科学 | 60篇 |
妇产科学 | 133篇 |
基础医学 | 143篇 |
口腔科学 | 99篇 |
临床医学 | 159篇 |
内科学 | 498篇 |
皮肤病学 | 57篇 |
神经病学 | 146篇 |
特种医学 | 64篇 |
外科学 | 248篇 |
综合类 | 9篇 |
一般理论 | 1篇 |
预防医学 | 63篇 |
眼科学 | 22篇 |
药学 | 94篇 |
中国医学 | 2篇 |
肿瘤学 | 152篇 |
出版年
2022年 | 16篇 |
2021年 | 38篇 |
2020年 | 13篇 |
2019年 | 33篇 |
2018年 | 26篇 |
2017年 | 22篇 |
2016年 | 41篇 |
2015年 | 41篇 |
2014年 | 46篇 |
2013年 | 90篇 |
2012年 | 109篇 |
2011年 | 112篇 |
2010年 | 59篇 |
2009年 | 58篇 |
2008年 | 110篇 |
2007年 | 128篇 |
2006年 | 135篇 |
2005年 | 117篇 |
2004年 | 105篇 |
2003年 | 112篇 |
2002年 | 90篇 |
2001年 | 17篇 |
2000年 | 25篇 |
1999年 | 25篇 |
1998年 | 9篇 |
1997年 | 18篇 |
1996年 | 18篇 |
1995年 | 15篇 |
1994年 | 14篇 |
1993年 | 13篇 |
1992年 | 26篇 |
1991年 | 21篇 |
1990年 | 23篇 |
1989年 | 26篇 |
1988年 | 15篇 |
1987年 | 15篇 |
1986年 | 16篇 |
1985年 | 14篇 |
1984年 | 20篇 |
1983年 | 14篇 |
1982年 | 13篇 |
1981年 | 10篇 |
1980年 | 7篇 |
1979年 | 9篇 |
1978年 | 11篇 |
1977年 | 11篇 |
1975年 | 7篇 |
1974年 | 8篇 |
1971年 | 7篇 |
1968年 | 7篇 |
排序方式: 共有1996条查询结果,搜索用时 15 毫秒
91.
92.
93.
Raul J. CardenasVijayakumar Javalkar Haim EzerJeremy Burnham Anil Nanda 《Journal of clinical neuroscience》2011,18(1):128-130
The occipital interhemispheric transtentorial approach is commonly used for pineal region tumors. However, there are few reports of this approach for lesions in the superior cerebellum. We present a 47-year-old male patient with an incidental cystic lesion in the superior cerebellum, detected on MRI consistent with cerebellar hemangioblastoma. The patient initially underwent stereotactic radiosurgery. After 5 months he presented with dizziness. A repeat MRI scan revealed an interval increase in lesion size. We performed surgery using the occipital interhemispheric transtentorial approach to remove the lesion. There were no intraoperative complications and the patient tolerated the procedure well. We describe our approach, supplemented by a short video, and review operative approaches to the superior cerebellum. 相似文献
94.
Haim Bitterman 《Critical care (London, England)》2009,13(1):205-8
Oxygen is one of the most commonly used therapeutic agents. Injudicious use of oxygen at high partial pressures (hyperoxia)
for unproven indications, its known toxic potential, and the acknowledged roles of reactive oxygen species in tissue injury
led to skepticism regarding its use. A large body of data indicates that hyperoxia exerts an extensive profile of physiologic
and pharmacologic effects that improve tissue oxygenation, exert anti-inflammatory and antibacterial effects, and augment
tissue repair mechanisms. These data set the rationale for the use of hyperoxia in a list of clinical conditions characterized
by tissue hypoxia, infection, and consequential impaired tissue repair. Data on regional hemodynamic effects of hyperoxia
and recent compelling evidence on its anti-inflammatory actions incited a surge of interest in the potential therapeutic effects
of hyperoxia in myocardial revascularization and protection, in traumatic and nontraumatic ischemicanoxic brain insults, and
in prevention of surgical site infections and in alleviation of septic and nonseptic local and systemic inflammatory responses.
Although the margin of safety between effective and potentially toxic doses of oxygen is relatively narrow, the ability to
carefully control its dose, meticulous adherence to currently accepted therapeutic protocols, and individually tailored treatment
regimens make it a cost-effective safe drug. 相似文献
95.
SIRT6, a protein with many faces 总被引:1,自引:0,他引:1
Sirtuins are NAD+ dependent deacylases enzymes. There are seven mammalian sirtuins, SIRT1–SIRT7, which are localized to different cellular compartments and are capable of diverse catalytic activities. SIRT6 is a key regulator of healthy ageing. In the past decade our understanding of SIRT6 significantly increased in many different aspects. We know its cellular localization, catalytic activities, substrates and the pathways it is involved in. This review discusses the recent discoveries regarding the SIRT6 enzyme. 相似文献
96.
This special issue of Disability and Rehabilitation is dedicated to the publication of nine articles by young P&RM researchers from different countries. These works reached the final stage in a competition – the Young Scientist Award — held during the 2nd World Congress of the International Society of Physical and Rehabilitation Medicine (ISPRM; Prague, Czech Republic, May 2003). The aim of this editorial paper is to analyse current trends in P&RM research as reflected in the above congress. 相似文献
97.
98.
Adi Zuloff-Shani Abraham Adunsky Haim Semo Jeremy Tamir Eli Regev Eilat Shinar 《Archives of gerontology and geriatrics》2010,51(3):268
The objective of this study was to compare local injections of AMS with SOC treatments for stage III and IV pressure ulcers in elderly patients. It was designed as historically prospective 2-arms non-parallel open controlled trial, and conducted in a department of geriatric medicine and rehabilitation of a university affiliated tertiary hospital. We studied 100 consecutive elderly patients with a total of 216 stage III or IV pressure ulcers, 66 patients were assigned to the AMS group and had their wounds injected, while 38 patients were assigned to the SOC group. Primary outcome was rate of complete wound closure. Time to complete wound closure and 1-year mortality served as secondary outcomes. Statistical analyses were performed at both patient and wound levels. Percentage of completely closed wounds (wound level and patient level) were significantly better (p < 0.001/p < 0.001, respectively) in all patients in favor of AMS, as well as in the subset of diabetic patients (p < 0.001/p < 0.001). Similarly, AMS proved significantly better for the subset of those with leg ulcers and with baseline wounds ≤15 cm2, compared with SOC. There were no statistically significant differences with regard to time to complete closure or 1-year mortality rates in the two groups. It is concluded that there is a significant difference in favor of stage III and IV wound closure rates by AMS, as compared with SOC treatments. 相似文献
99.
PURPOSE: To compare the prognosis of patients with a first Q-wave versus non-Q-wave myocardial infarction (MI) in the reperfusion era. METHODS: Patients with a first MI were compared according to type of infarct-Q-wave (n = 1,786) versus non-Q-wave (n = 722)-and by treatment with thrombolysis. RESULTS: Patients with non-Q-wave MI were more likely to be female and to have undergone previous coronary revascularization. Their 30-day mortality rate was 7%, as compared with a rate of 9% among patients with Q-wave infarction (adjusted odds ratio [OR] = 0.6, 95% confidence interval [CI]: 0.4 to 0.9). However, the subsequent 30-day to 1-year mortality rates were similar in patients with Q-wave or non-Q-wave MI. Patients who were not treated with thrombolysis and who had a non-Q-wave MI had a lower 30-day mortality rate (OR = 0.6, 95% CI: 0.3 to 0.9) but a similar 30-day to 1-year mortality rate (hazard ratio [HR] = 1.5, 95% CI: 0.9 to 2.5) as compared with their counterparts who developed Q-wave infarction. Among thrombolysis-treated patients, 30-day (OR = 0.8, 95% CI: 0.4 to 1.5) as well as 30-day to 1-year (HR = 1.2, 95% CI: 0.5 to 3.0) mortality rates were similar between patients who developed either Q-wave or non-Q-wave MI. CONCLUSIONS: Patients who received thrombolysis had similar early and late mortality rates after the index infarction regardless of whether they had a Q-wave or non-Q-wave MI. Conversely, among patients who were not treated with thrombolysis, patients with a non-Q-wave MI had lower early mortality rates but similar long-term mortality rates as those with Q-wave MI. 相似文献
100.
Martha Dirnfeld Yael Gonen Arie Lissak Shlomit Goldman Mara Koifman Yoram Sorokin Haim Abramovici 《Journal of assisted reproduction and genetics》1991,8(6):339-343
Fifty four women with repeated unsuccessful in vitro fertilization (IVF) cycles due to inadequate ovarian response to stimulation with human menopausal gonadotropins (hMG) participated in this study. They were randomized to receive either gonadotropin releasing hormone agonist (GNRHa), Buserelin, prior to and during induction of ovulation by hMG (Group I—long protocol), or GnRHa starting on the first day of the cycle together with induction of ovulation by hMG (Group II—short protocol). Mean follicular phase serum luteinizing hormone (LH) and progesterone (P) levels were significantly lower in Group I than in Group II (P<0.01). Cancellation rate was significantly lower in Group I than in Group II (P<0.01). The long GNRHa protocol resulted in statistically significant lower cancellation rates, more oocytes per pickup (OPU), more embryos trans-ferred per patient, and a higher pregnancy rate. Significantly more hMG ampoules and more treatments days were required in the long GNRHa protocol. Our data demonstrate that the use of GNRHa prior to and during ovarian stimulation with hMG offers a very good alternative for patients with repetitive unsuccessful IVF cycles due to inadequate response. 相似文献